ADE - Antibody-dependent Enhancement and Immunopathology/Immunotherapy

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/15

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

16 Terms

1
New cards

What is Antibody-dependent enhancement?

Certain pathogens induce strong immune responses but have

evolved strategies to escape killing

Persistence of infection results from ability to survive

Infection with a second serotype (different than the original) or a

different virus can worsen the course of the disease because of the

antibodies raised against the first serotype

Bottom line strategy: “Antibodies as a Trojan horse” to generate a strong secondary infection (Fc receptors on the phagocytic cells interact with the Fc part of the antibodies)

<p>Certain pathogens induce strong immune responses but have</p><p>evolved strategies to escape killing</p><p><span data-name="black_medium_square" data-type="emoji">◼</span> Persistence of infection results from ability to survive</p><p><span data-name="black_medium_square" data-type="emoji">◼</span> Infection with a second serotype (different than the original) or a</p><p>different virus can worsen the course of the disease because of the</p><p>antibodies raised against the first serotype</p><p><span data-name="black_medium_square" data-type="emoji">◼</span> Bottom line strategy: “Antibodies as a Trojan horse” to generate a strong secondary infection (Fc receptors on the phagocytic cells interact with the Fc part of the antibodies)</p>
2
New cards

Explain infection with DENV and ADE.

DENV receptor activates PRR signalling which produces type 1 interferon proinflammatory cytokine which inhibits viral replication
For ADE infection
Fc receptor suppresses PRR signalling and inhibits type 1 interferon proinflammatory cytokine (with IL-10 +SOCS) and activates Th2 bias.

<p><strong>DENV receptor</strong> activates PRR signalling which produces type 1 interferon proinflammatory cytokine which inhibits viral replication<br><strong>For ADE infection</strong><br><strong>Fc receptor </strong>suppresses PRR signalling and inhibits  type 1 interferon proinflammatory cytokine (with IL-10 +SOCS) and activates Th2 bias. </p>
3
New cards

What is autoimmunity? Use a diagram to support your answer.

An inappropriate immune response

against a self antigen

<p>An inappropriate immune response</p><p>against a self antigen</p>
4
New cards

What is tolerance? Use a diagram to support your answer.

mechanisms that exist to

protect an individual from potentially

self-reactive lymphocytes

<p>mechanisms that exist to</p><p>protect an individual from potentially</p><p>self-reactive lymphocytes</p>
5
New cards

Explain how the foetus is an allograft?

Foetus is an allograft that is not rejected

Allograft - a tissue graft from a donor of the

same species as the recipient but not

genetically identical

<p>Foetus is an allograft that is not rejected</p><p> Allograft - a tissue graft from a donor of the</p><p>same species as the recipient but not</p><p>genetically identical</p>
6
New cards

What is foetal tolerance?

Fetal tolerance refers to the unique immunological phenomenon in which the maternal immune system tolerates the presence of the semi-allogeneic fetus, allowing pregnancy to proceed without rejection. This tolerance is remarkable because the fetus expresses paternal antigens that are foreign to the maternal immune system, which under normal circumstances would trigger an immune response.

7
New cards

In foetal tolerance, describe immune privilege.

Tolerance to the introduction of antigens without

eliciting an inflammatory immune response

Tissue grafts are normally recognized as foreign

antigen by the body and attacked by the immune

system

8
New cards

Where are the immune privileged sites in allografts?

In immune privileged sites - tissue grafts can

survive for extended periods of time without

rejection occurring

Immunologically privileged sites include

eyes

placenta and fetus

testicles

central nervous system

anagen hair follicle

9
New cards

What is hypersensitivity?

Hypersensitivity refers to exaggerated or inappropriate immune responses to harmless antigens, leading to tissue damage and clinical disease.

10
New cards

Explain type I hypersensitivity.

Mechanism:

Caused by the activation of IgE antibodies and their interaction with mast cells and basophils.

Upon initial exposure, the allergen induces IgE production by B cells. IgE binds to Fcε receptors on mast cells, sensitizing them.

On subsequent exposure, the allergen cross-links IgE on mast cells, leading to degranulation and release of inflammatory mediators (e.g., histamine, leukotrienes, prostaglandins).

Onset: Within minutes of allergen exposure.

Examples:

Allergic rhinitis (hay fever), asthma, anaphylaxis, food allergies, urticaria (hives).

11
New cards

What is an immunodeficiency?

Primary – a group of disorders

characterized by an inability to produce

a normal immune response (genetic)

  • Characterized by recurrent infections, high risk of autoimmune diseases, allergy and cancer

Secondary – Abnormal immune

response caused by an external force

(acquired)

E.g. infection, tumour, medications, etc.

12
New cards

Describe cancer’s role in immunopathology. Use a diagram to support your answer.

Results from a lack of immune surveillance

Cells or secreted molecules can

  1. Induce CTL apoptosis

  2. Suppress CD8+ T cell-mediated immunity

  3. Cause immune exhaustion

  4. Downregulate molecules involved in T cell activation

<p> Results from a lack of immune surveillance</p><p><span data-name="black_medium_square" data-type="emoji">◼</span> Cells or secreted molecules can</p><ol><li><p> Induce CTL apoptosis</p></li><li><p> Suppress CD8+ T cell-mediated immunity</p></li><li><p>Cause immune exhaustion</p></li><li><p>Downregulate molecules involved in T cell activation</p></li></ol><p></p>
13
New cards

What is immunetherapy?

Immunotherapy is a medical treatment that harnesses and modifies the immune system to fight diseases, particularly cancer, autoimmune conditions, and allergies. It involves enhancing, suppressing, or manipulating immune responses to achieve therapeutic goals.

14
New cards

What is cancer immunotherapy? Give two examples

Cancer Immunotherapy

Designed to stimulate the immune system to recognize and destroy cancer cells.

Examples:

Checkpoint Inhibitors:

Drugs like nivolumab or pembrolizumab block immune checkpoints (e.g., PD-1/PD-L1 or CTLA-4) that suppress T-cell activity, reactivating the immune system against cancer.

CAR-T Cell Therapy:

T cells are engineered to express chimeric antigen receptors (CARs) that specifically target cancer antigens. These cells are reinfused into the patient to attack tumors.

15
New cards

What is a type of immunotherapy for autoimmunity? Give two examples

Autoimmune Disease Immunotherapy

Suppresses the immune system to prevent it from attacking self-tissues.

Examples:

Biologic Drugs:

TNF inhibitors (e.g., infliximab) for rheumatoid arthritis and Crohn’s disease.

IL-17 inhibitors for psoriasis.

Immune Cell Depletion:

Rituximab targets CD20 on B cells in diseases like lupus or multiple sclerosis.

16
New cards

Illustrate hypersensitivity immunotherapy.